Literature DB >> 21178856

Is local excision after complete pathological response to neoadjuvant chemoradiation for rectal cancer an acceptable treatment option?

Yulia Kundel1, Ronen Brenner, Ofer Purim, Nir Peled, Efraim Idelevich, Eyal Fenig, Aaron Sulkes, Baruch Brenner.   

Abstract

PURPOSE: The role of local excision in patients with good histological response to neoadjuvant chemoradiation for locally advanced rectal cancer is unclear, mainly because of possible regional nodal involvement. This study aims to evaluate the correlation between pathological T and N stages following neoadjuvant chemoradiation for locally advanced rectal cancer and the outcome of patients with mural pathological complete response undergoing local excision.
METHODS: This investigation was conducted as a retrospective analysis. Between January 1997 and December 2007, 320 patients with T3 to 4Nx, TxN+ or distal (≤ 6 cm from the anus) T2N0 rectal cancer underwent neoadjuvant concurrent chemoradiation followed by surgery. Radiotherapy was standard and chemotherapy consisted of common fluoropyrimidine-based regimens.
RESULTS: After chemoradiation, 93% patients had radical surgery, 6% had local excision, and 3% did not have surgery. In the 291 patients undergoing radical surgery, the pathological T stage correlated with the N stage (P = .036). We compared the outcome of patients with mural complete pathological response (n = 37) who underwent radical surgery (group I) and those (n = 14) who had local excision only (group II). With a median follow-up of 48 months, 4 patients in group I had a recurrence and none in group II had a recurrence; one patient died in group I and none died in group II. Disease-free survival, pelvic recurrence-free survival, and overall survival rates were similar in both groups.
CONCLUSION: In this retrospective study, nodal metastases were rare in patients with mural complete pathological response following neoadjuvant chemoradiation (3%), and local excision did not compromise their outcome. Therefore, local excision may be an acceptable option in these patients.

Entities:  

Mesh:

Year:  2010        PMID: 21178856     DOI: 10.1007/DCR.0b013e3181f5b64d

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  22 in total

Review 1.  Oncological outcomes of local excision compared with radical surgery after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis.

Authors:  Irshad Shaikh; Alan Askari; Suzana Ourû; Janindra Warusavitarne; Thanos Athanasiou; Omar Faiz
Journal:  Int J Colorectal Dis       Date:  2014-11-04       Impact factor: 2.571

Review 2.  Transanal Minimally Invasive Surgery.

Authors:  Teresa deBeche-Adams; George Nassif
Journal:  Clin Colon Rectal Surg       Date:  2015-09

3.  Transanal Minimally Invasive Surgery (TAMIS): a clinical spotlight review.

Authors:  Teresa deBeche-Adams; Imran Hassan; Stephen Haggerty; Dimitrios Stefanidis
Journal:  Surg Endosc       Date:  2017-06-27       Impact factor: 4.584

4.  Management of distal rectal cancer: results from a national survey.

Authors:  G Melotti; E De Antoni; A Habr-Gama; A Minicozzi
Journal:  Updates Surg       Date:  2013-01-19

5.  Is It Possible a Conservative Approach After Radiochemotherapy in Locally Advanced Rectal Cancer (LARC)? A Systematic Review of the Literature and Meta-analysis.

Authors:  Francesco Fiorica; Marco Trovò; Gabriele Anania; Daniele Marcello; Fabrizio Di Benedetto; Marina Marzola; Fabrizio D'Acapito; Guglielmo Nasti; Massimiliano Berretta
Journal:  J Gastrointest Cancer       Date:  2019-03

6.  The risk of nodal disease in patients with pathological complete responses after neoadjuvant chemoradiation for rectal cancer: a systematic review, meta-analysis, and meta-regression.

Authors:  Ian Jun Yan Wee; Hai Man Cao; James Chi-Yong Ngu
Journal:  Int J Colorectal Dis       Date:  2019-07-04       Impact factor: 2.571

Review 7.  Current issues in locally advanced colorectal cancer treated by preoperative chemoradiotherapy.

Authors:  In Ja Park; Chang Sik Yu
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

8.  p27 expression in post-treatment rectal cancer: a potential novel approach for predicting residual nodal disease.

Authors:  Tobias Leibold; Vanessa W Hui; Jinru Shia; Jeannine A Ruby; Elyn R Riedel; José G Guillem
Journal:  Am J Surg       Date:  2014-04-13       Impact factor: 2.565

Review 9.  Risk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancers.

Authors:  Jia-Yuan Peng; Zhong-Nan Li; Yu Wang
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

Review 10.  Treatment of locally advanced rectal cancer: controversies and questions.

Authors:  Atthaphorn Trakarnsanga; Suthinee Ithimakin; Martin R Weiser
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.